Pre-surgical CT Scan Assessment of Bone Mineral Density Before Resection of NHO of the Hip

Paraosteoarthropathies Clinical Trial

Official title:

Pre-surgical CT Scan Assessment of Femoral Head Bone Mineral Density Before Resection of Neurogenic Heterotopic Ossification (NHO) of the Hip

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03914521
• Other study ID #: RECHMPL19_0095
• Status: Completed
• Start date: March 1, 2019
• Est. completion date: September 1, 2020

Study information

• Verified date: December 2020
• Source: University Hospital, Montpellier
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Neurogenic heterotopic ossification (NHO) is defined as an ectopic ossification around proximal joints usually seen after traumatic brain injury, spinal cord injury or polytrauma.

NHO causes pain, partial or total joint ankylosis and vascular or nerve complications.

The osteopenia (low bone density) induced by ankylose increases the fracture risk of femoral neck during the hip surgery performed to remove the NHO.

The analyse of femoral head bone mineral density from hip pre-surgical CT scan could anticipate this kind of complication establishing a presurgical prognostic.

If as it turns out the bone density measured from hip pre-surgical CT scan is relevant fracture risk marker, a preventive osteosynthesis or femoral head and neck resection could be performed in the same time of NHO resection.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 40
• Est. completion date: September 1, 2020
• Est. primary completion date: March 1, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients aged 18 years and over

• Patients having surgery resection of surgery resection of Neurogenic heterotopic ossification of hip.

• Patients with pre-surgery CT-scan and surgery report available

Exclusion criteria:

• Minor patients

• Patients didn't have surgery surgery resection of Neurogenic heterotopic ossification of hip.

• Pre-surgery CT-scan and surgery report not available

Exclusion Criteria:

-

Related Conditions & MeSH terms

• Paraosteoarthropathies

Locations

Country	Name	City	State
France	Uhmontpellier	Montpellier

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Montpellier

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	femoral head bone mineral density	femoral head bone mineral density	1 year